Literature DB >> 8277225

Tumour necrosis factor-alpha modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro.

D N Danforth1, M K Sgagias.   

Abstract

We studied the effect of tumour necrosis factor-alpha (TNF) on oestradiol regulation of growth and metabolism of MCF-7 breast cancer cells to determine whether TNF altered the oestradiol responsiveness of these cells. We found that TNF antagonized oestradiol stimulation of cell growth in a dose-dependent manner, with partial inhibition at 1.0 U/ml and complete inhibition at 1000 U/ml. TNF inhibited cell cycle progression, increasing cells in the G0G1 phase and blocking oestradiol-stimulated progression into the S phase. We examined the effect of TNF on three oestrogen-regulated proteins, the oestrogen receptor (ER), the progesterone receptor (PR) and insulin-like growth factor-I (IGF-I). TNF down-regulated the ER and up-regulated the PR. Both of these processes were enhanced by the addition of oestradiol. The effects of TNF on the ER and PR were dose-dependent and occurred without a change in the Kd of the receptor. TNF did not change the respective steady-state mRNA levels. In addition, TNF did not alter secretion of IGF-I either in the absence or presence of oestradiol, indicating that the effects of TNF on oestrogen-regulated proteins in selective. These findings indicate an important interaction between the immune and endocrine systems. The cytokine TNF has a prominent effect on oestradiol stimulation of MCF-7 cells, blocking its proliferative response and enhancing certain metabolic effects. These actions may be mediated in part through modulation of the ER, although other pathways appear to be involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8277225     DOI: 10.1677/joe.0.1380517

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients.

Authors:  Eskandar Kamali-Sarvestani; Behrouz Gharesi-Fard; Jamal Sarvari; Abd-Al-Rasoul Talei
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha.

Authors:  Bridgette M Collins-Burow; James W Antoon; Daniel E Frigo; Steven Elliott; Christopher B Weldon; Stephen M Boue; Barbara S Beckman; Tyler J Curiel; Jawed Alam; John A McLachlan; Matthew E Burow
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-24       Impact factor: 4.292

3.  Adipocytes enhance the proliferation of human leiomyoma cells via TNF-α proinflammatory cytokine.

Authors:  Sangeeta Nair; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2011-12       Impact factor: 3.060

4.  Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function.

Authors:  P Bhat-Nakshatri; R A Campbell; N M Patel; T R Newton; A J King; M S Marshall; S Ali; H Nakshatri
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

Review 5.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

6.  Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells.

Authors:  Pabbisetty Sudheer Kumar; Anjali Shiras; Gowry Das; Jayashree C Jagtap; Vandna Prasad; Padma Shastry
Journal:  Mol Cancer       Date:  2007-06-12       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.